CBSA advocates for policies that improve patient access to life-saving novel technologies. This week, CBSA signed on to a letter responding to the long-awaited proposed Transitional Coverage for Emerging Technologies (TCET) pathway, which is an important opportunity for our industry and CMS to modernize the coverage process, allowing swifter access to innovative technologies and therapies for Medicare beneficiaries.
Spearheaded by our national partners at AdvaMed’s State Medical Technology Alliance, the letter offers recommendations to improve the existing TCET proposal. While the TCET notice released in late June is a positive step forward, we believe more can be done to ensure patients have timely access to new technologies soon after they are approved by the FDA.
CBSA and Partner Engagement on TCET
CBSA is collaborating with our national partners at AdvaMed and MDMA on outreach regarding TCET.
In October 2022, CBSA encouraged members of the Colorado Congressional Delegation…
Click here to view original post
